chr1-99884201-A-G

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000642.3(AGL):​c.2390A>G​(p.Asn797Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00283 in 1,613,298 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0020 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0029 ( 14 hom. )

Consequence

AGL
NM_000642.3 missense

Scores

1
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:6O:2

Conservation

PhyloP100: 8.63

Publications

3 publications found
Variant links:
Genes affected
AGL (HGNC:321): (amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase) This gene encodes the glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in this gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
AGL Gene-Disease associations (from GenCC):
  • glycogen storage disease III
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, Myriad Women’s Health

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020510167).
BP6
Variant 1-99884201-A-G is Benign according to our data. Variant chr1-99884201-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 456470.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00205 (312/152328) while in subpopulation NFE AF = 0.00284 (193/67994). AF 95% confidence interval is 0.00251. There are 3 homozygotes in GnomAd4. There are 132 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000642.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGL
NM_000642.3
MANE Select
c.2390A>Gp.Asn797Ser
missense
Exon 18 of 34NP_000633.2P35573-1
AGL
NM_000028.3
c.2390A>Gp.Asn797Ser
missense
Exon 18 of 34NP_000019.2P35573-1
AGL
NM_000643.3
c.2390A>Gp.Asn797Ser
missense
Exon 18 of 34NP_000634.2A0A0S2A4E4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
AGL
ENST00000361915.8
TSL:1 MANE Select
c.2390A>Gp.Asn797Ser
missense
Exon 18 of 34ENSP00000355106.3P35573-1
AGL
ENST00000294724.8
TSL:1
c.2390A>Gp.Asn797Ser
missense
Exon 18 of 34ENSP00000294724.4P35573-1
AGL
ENST00000370163.7
TSL:1
c.2390A>Gp.Asn797Ser
missense
Exon 18 of 34ENSP00000359182.3P35573-1

Frequencies

GnomAD3 genomes
AF:
0.00205
AC:
312
AN:
152210
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.0824
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000470
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00284
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00176
AC:
441
AN:
250870
AF XY:
0.00186
show subpopulations
Gnomad AFR exome
AF:
0.000370
Gnomad AMR exome
AF:
0.00197
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000740
Gnomad NFE exome
AF:
0.00279
Gnomad OTH exome
AF:
0.00278
GnomAD4 exome
AF:
0.00291
AC:
4254
AN:
1460970
Hom.:
14
Cov.:
31
AF XY:
0.00282
AC XY:
2050
AN XY:
726850
show subpopulations
African (AFR)
AF:
0.000359
AC:
12
AN:
33448
American (AMR)
AF:
0.00224
AC:
100
AN:
44680
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26108
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39572
South Asian (SAS)
AF:
0.000429
AC:
37
AN:
86230
European-Finnish (FIN)
AF:
0.000749
AC:
40
AN:
53406
Middle Eastern (MID)
AF:
0.000521
AC:
3
AN:
5758
European-Non Finnish (NFE)
AF:
0.00352
AC:
3908
AN:
1111404
Other (OTH)
AF:
0.00253
AC:
153
AN:
60364
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
196
392
588
784
980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00205
AC:
312
AN:
152328
Hom.:
3
Cov.:
32
AF XY:
0.00177
AC XY:
132
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.000216
AC:
9
AN:
41592
American (AMR)
AF:
0.00183
AC:
28
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.000470
AC:
5
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00284
AC:
193
AN:
67994
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
15
31
46
62
77
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00136
Hom.:
12
Bravo
AF:
0.00261
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00234
AC:
9
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00337
AC:
29
ExAC
AF:
0.00152
AC:
185
EpiCase
AF:
0.00262
EpiControl
AF:
0.00373

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
4
3
Glycogen storage disease type III (8)
-
2
2
not provided (5)
-
-
1
AGL-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T
Eigen
Uncertain
0.61
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.021
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.8
M
PhyloP100
8.6
PrimateAI
Uncertain
0.49
T
PROVEAN
Uncertain
-3.2
D
REVEL
Benign
0.20
Sift
Benign
0.064
T
Sift4G
Benign
0.10
T
Polyphen
0.80
P
Vest4
0.77
MVP
0.58
MPC
0.13
ClinPred
0.045
T
GERP RS
5.8
Varity_R
0.43
gMVP
0.61
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149210307; hg19: chr1-100349757; API